|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD, Fedewa SA, Ahnen DJ,
Meester RGS, Barzi A and Jemal A: Colorectal cancer statistics,
2017. CA Cancer J Clin. 67:177–193. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lopes GS, Lico DTP, Silva-Rocha R, de
Oliveira RR, Sebollela A, Paçó-Larson ML and Larson RE: A
phylogenetically conserved hnRNP type A/B protein from squid brain.
Neurosci Lett. 696:219–224. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Geuens T, Bouhy D and Timmerman V: The
hnRNP family: Insights into their role in health and disease. Hum
Genet. 135:851–867. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Weighardt F, Biamonti G and Riva S: The
roles of heterogeneous nuclear ribonucleoproteins (hnRNP) in RNA
metabolism. Bioessays. 18:747–756. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sinnamon JR, Waddell CB, Nik S, Chen EI
and Czaplinski K: Hnrpab regulates neural development and neuron
cell survival after glutamate stimulation. RNA. 18:704–719. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lampasona AA and Czaplinski K: Hnrnpab
regulates neural cell motility through transcription of Eps8. RNA.
25:45–59. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu X, Zhou Y, Lou Y and Zhong H:
Knockdown of HNRNPA1 inhibits lung adenocarcinoma cell
proliferation through cell cycle arrest at G0/G1 phase. Gene.
576:791–797. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhou ZJ, Dai Z, Zhou SL, Hu ZQ, Chen Q,
Zhao YM, Shi YH, Gao Q, Wu WZ, Qiu SJ, et al: HNRNPAB induces
epithelial-mesenchymal transition and promotes metastasis of
hepatocellular carcinoma by transcriptionally activating SNAIL.
Cancer Res. 74:2750–2762. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sakuma K, Sasaki E, Kimura K, Komori K,
Shimizu Y, Yatabe Y and Aoki M: HNRNPLL, a newly identified
colorectal cancer metastasis suppressor, modulates alternative
splicing of CD44 during epithelial-mesenchymal transition. Gut.
67:1103–1111. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Khan FA, Jaiswal AK and Szer W: Cloning
and sequence analysis of a human type A/B hnRNP protein. FEBS Lett.
290:159–161. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Czaplinski K, Kocher T, Schelder M, Segref
A, Wilm M and Mattaj IW: Identification of 40LoVe, a Xenopus hnRNP
D family protein involved in localizing a TGF-beta-related mRNA
during oogenesis. Dev Cell. 8:505–515. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chettouh H, Fartoux L, Aoudjehane L,
Wendum D, Clapéron A, Chrétien Y, Rey C, Scatton O, Soubrane O,
Conti F, et al: Mitogenic insulin receptor-A is overexpressed in
human hepatocellular carcinoma due to EGFR-mediated dysregulation
of RNA splicing factors. Cancer Res. 73:3974–3986. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Han SP, Tang YH and Smith R: Functional
diversity of the hnRNPs: Past, present and perspectives. Biochem J.
430:379–392. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Roy R, Huang Y, Seckl MJ and Pardo OE:
Emerging roles of hnRNPA1 in modulating malignant transformation.
Wiley Interdiscip Res RNA. 8:102017.
|
|
16
|
Meredith EK, Balas MM, Sindy K, Haislop K
and Johnson AM: An RNA matchmaker protein regulates the activity of
the long noncoding RNA HOTAIR. RNA. 22:995–1010. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kuranaga Y, Sugito N, Shinohara H, Tsujino
T and Taniguchi K: SRSF3, a splicer of the PKM gene, regulates cell
growth and maintenance of cancer-specific energy metabolism in
colon cancer cells. Int J Mol Sci. 2:E30122018. View Article : Google Scholar
|
|
18
|
Amin MB, Greene FL, Edge SB, Compton CC,
Gershenwald JE, Brookland RK, Meyer L, Gress DM, Byrd DR and
Winchester DP: The eighth edition AJCC Cancer staging manual:
Continuing to build a bridge from a population-based to a more
‘personalized’ approach to cancer staging. CA Cancer J Clin.
67:93–99. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wen KM, Zhang GH, Li J, Chen ZQ, Cheng YL,
Su X and Zeng QL: OCT4B1 promotes cell growth, migration and
invasion suppressing sensitivity to omicronxaliplatin in colon
cancer. Oncol Rep. 34:2943–2952. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xuan Y, Wang J, Ban L, Lu JJ, Yi C, Li Z,
Yu W, Li M, Xu T, Yang W, et al: hnRNPA2/B1 activates
cyclooxygenase-2 and promotes tumor growth in human lung cancers.
Mol Oncol. 10:610–624. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Loh TJ, Moon H, Cho S, Jang H, Liu YC, Tai
H, Jung DW, Williams DR, Kim HR, Shin MG, et al: CD44 alternative
splicing and hnRNP A1 expression are associated with the metastasis
of breast cancer. Oncol Rep. 34:1231–1238. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhou J, Allred DC, Avis I, Martínez A, Vos
MD, Smith L, Treston AM and Mulshine JL: Differential expression of
the early lung cancer detection marker, heterogeneous nuclear
ribonucleoprotein-A2/B1 (hnRNP-A2/B1) in normal breast and
neoplastic breast cancer. Breast Cancer Res Treat. 66:217–224.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dai S, Zhang J, Huang S, Lou B, Fang B, Ye
T, Huang X, Chen B and Zhou M: HNRNPA2B1 regulates the
epithelial-mesenchymal transition in pancreatic cancer cells
through the ERK/snail signalling pathway. Cancer Cell Int.
17:122017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Brandi J, Cecconi D, Cordani M,
Torrens-Mas M, Pacchiana R, Dalla Pozza E, Butera G, Manfredi M,
Marengo E and Oliver J: The antioxidant uncoupling protein 2
stimulates hnRNPA2/B1, GLUT1 and PKM2 expression and sensitizes
pancreas cancer cells to glycolysis inhibition. Free Radic Biol
Med. 101:305–316. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hope NR and Murray GI: The expression
profile of RNA-binding proteins in primary and metastatic
colorectal cancer: Relationship of heterogeneous nuclear
ribonucleoproteins with prognosis. Hum Pathol. 42:393–402. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Roda D, Castillo J, Telechea-Fernandez M,
Gil A, López-Rodas G, Franco L, González-Rodríguez P, Roselló S,
Pérez-Fidalgo JA, García-Trevijano ER, et al: EGF-Induced
acetylation of heterogeneous nuclear ribonucleoproteins is
dependent on KRAS mutational status in colorectal cancer cells.
PLoS One. 10:e01305432015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Huang JZ, Chen M, Che n, Gao XC, Zhu S,
Huang H, Hu M, Zhu H and Yan GR: A peptide encoded by a putative
lncRNA HOXB-AS3 suppresses colon cancer growth. Mol Cell.
68:171–184. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hua JT, Ahmed M, Guo H, Zhang Y, Chen S,
Soares F, Lu J, Zhou S, Wang M, Li H, et al: Risk SNP-mediated
promoter-enhancer switching drives prostate cancer through lncRNA
PCAT19. Cell. 174:564–575. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ma YL, Peng JY, Zhang P, Huang L, Liu WJ,
Shen TY, Chen HQ, Zhou YK, Zhang M, Chu ZX and Qin HL:
Heterogeneous nuclear ribonucleoprotein A1 is identified as a
potential biomarker for colorectal cancer based on differential
proteomics technology. J Proteome Res. 8:4525–4535. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Duffy MJ, Lamerz R, Haglund C, Nicolini A,
Kalousová M, Holubec L and Sturgeon C: Tumor markers in colorectal
cancer, gastric cancer and gastrointestinal stromal cancers:
European group on tumor markers 2014 guidelines update. Int J
Cancer. 134:2513–2522. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Strimpakos AS, Cunningham D, Mikropoulos
C, Petkar I, Barbachano Y and Chau I: The impact of
carcinoembryonic antigen flare in patients with advanced colorectal
cancer receiving first-line chemotherapy. Ann Oncol. 21:1013–1019.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Mitsuyama Y, Shiba H, Haruki K, Fujiwara
Y, Furukawa K, Iida T, Hayashi T, Ogawa M, Ishida Y, Misawa T, et
al: Carcinoembryonic antigen and carbohydrate antigen 19-9 are
prognostic predictors of colorectal cancer with unresectable liver
metastasis. Oncol Lett. 3:767–771. 2012.PubMed/NCBI
|
|
33
|
Nozawa H, Ishihara S, Kawai K, Hata K,
Kiyomatsu T, Tanaka T, Nishikawa T, Otani K, Yasuda K, Sasaki K, et
al: A high preoperative carbohydrate antigen 19-9 level is a risk
factor for recurrence in stage II colorectal cancer. Acta Oncol.
56:634–638. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Park WC, Kim HR, Kang DB, Ryu JS, Choi KH,
Lee GO, Yun KJ, Kim KY, Park R, Yoon KH, et al: Comparative
expression patterns and diagnostic efficacies of SR splicing
factors and HNRNPA1 in gastric and colorectal cancer. BMC Cancer.
16:3582016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yang Y and Chen Q: HNRNPAB-regulated
lncRNA-ELF209 inhibits the malignancy of hepatocellular carcinoma.
Int J Cancer. 15:102019.
|
|
36
|
Warns JA, Davie JR and Dhasarathy A:
Connecting the dots: Chromatin and alternative splicing in EMT.
Biochem Cell Biol. 94:12–25. 2016. View Article : Google Scholar : PubMed/NCBI
|
